{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T23:18:06Z","timestamp":1782861486120,"version":"3.54.5"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T00:00:00Z","timestamp":1751500800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T00:00:00Z","timestamp":1751500800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"crossref","award":["2022R1A6A1A03055869"],"award-info":[{"award-number":["2022R1A6A1A03055869"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"crossref","award":["NRF-2023R1A2C1006359"],"award-info":[{"award-number":["NRF-2023R1A2C1006359"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Virol"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s00705-025-06358-7","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T22:31:59Z","timestamp":1751495519000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Antagonistic effect of kanamycin on kanamycin-resistant Escherichia coli infection by BtuB-targeting bacteriophages"],"prefix":"10.1007","volume":"170","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-4498-7084","authenticated-orcid":false,"given":"Yewon","family":"Jung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7876-0390","authenticated-orcid":false,"given":"Jinshil","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5812-3394","authenticated-orcid":false,"given":"Sangryeol","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,3]]},"reference":[{"key":"6358_CR1","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1146\/annurev-med-080219-122208","volume":"73","author":"GF Hatfull","year":"2022","unstructured":"Hatfull GF, Dedrick RM, Schooley RT (2022) Phage therapy for antibiotic-resistant bacterial infections. Annu Rev Med 73:197\u2013211","journal-title":"Annu Rev Med"},{"key":"6358_CR2","doi-asserted-by":"crossref","unstructured":"Suh GA, Lodise TP, Tamma PD, Knisely JM, Alexander J, Aslam S, Barton KD, Bizzell E, Totten KMC, Campbell JL, Chan BK, Cunningham SA, Goodman KE, Greenwood-Quaintance KE, Harris AD, Hesse S, Maresso A, Nussenblatt V, Pride D, Rybak MJ, Sund Z, van Duin D, Van Tyne D, Patel R (2022) Antibacterial Resistance Leadership G Considerations for the use of phage therapy in clinical practice. Antimicrob Agents Chemother 66:e0207121","DOI":"10.1128\/aac.02071-21"},{"key":"6358_CR3","doi-asserted-by":"crossref","unstructured":"Gordillo Altamirano FL, Barr JJ (2019) Phage therapy in the postantibiotic era. Clin Microbiol Rev 32","DOI":"10.1128\/CMR.00066-18"},{"key":"6358_CR4","doi-asserted-by":"publisher","first-page":"e799","DOI":"10.1371\/journal.pone.0000799","volume":"2","author":"AM Comeau","year":"2007","unstructured":"Comeau AM, Tetart F, Trojet SN, Prere MF, Krisch HM (2007) Phage-antibiotic synergy (PAS): beta-lactam and quinolone antibiotics stimulate virulent phage growth. PLoS ONE 2:e799","journal-title":"PLoS ONE"},{"key":"6358_CR5","doi-asserted-by":"crossref","unstructured":"Kunz Coyne AJ, Stamper K, El Ghali A, Kebriaei R, Biswas B, Wilson M, Deschenes MV, Tran TT, Arias CA, Rybak MJ (2023) Phage-antibiotic cocktail rescues daptomycin and phage susceptibility against daptomycin-nonsusceptible Enterococcus faecium in a simulated endocardial vegetation Ex vivo model. Microbiol Spectr 11:e0034023","DOI":"10.1128\/spectrum.00340-23"},{"key":"6358_CR6","doi-asserted-by":"publisher","first-page":"e0050424","DOI":"10.1128\/mbio.00504-24","volume":"15","author":"AM Al-Anany","year":"2024","unstructured":"Al-Anany AM, Fatima R, Nair G, Mayol JT, Hynes AP (2024) Temperate phage-antibiotic synergy across antibiotic classes reveals new mechanism for preventing lysogeny. mBio 15:e0050424","journal-title":"mBio"},{"key":"6358_CR7","doi-asserted-by":"crossref","unstructured":"Manohar P, Madurantakam Royam M, Loh B, Bozdogan B, Nachimuthu R, Leptihn S (2022) Synergistic effects of phage-antibiotic combinations against Citrobacter amalonaticus. ACS Infect Dis 8:59\u201365","DOI":"10.1021\/acsinfecdis.1c00117"},{"key":"6358_CR8","doi-asserted-by":"crossref","unstructured":"Kim J, Hur JI, Ryu S, Jeon B (2021) Bacteriophage-mediated modulation of bacterial competition during selective enrichment of Campylobacter. Microbiol Spectr 9:e0170321","DOI":"10.1128\/Spectrum.01703-21"},{"key":"6358_CR9","doi-asserted-by":"crossref","unstructured":"Gu Liu C, Green SI, Min L, Clark JR, Salazar KC, Terwilliger AL, Kaplan HB, Trautner BW, Ramig RF, Maresso AW (2020) Phage-antibiotic synergy is driven by a unique combination of antibacterial mechanism of action and stoichiometry. mBio 11","DOI":"10.1128\/mBio.01462-20"},{"key":"6358_CR10","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/nrmicro2333","volume":"8","author":"MA Kohanski","year":"2010","unstructured":"Kohanski MA, Dwyer DJ, Collins JJ (2010) How antibiotics kill bacteria: from targets to networks. Nat Rev Microbiol 8:423\u2013435","journal-title":"Nat Rev Microbiol"},{"key":"6358_CR11","doi-asserted-by":"publisher","first-page":"2S","DOI":"10.1016\/0002-9343(89)90010-7","volume":"87","author":"LM Fisher","year":"1989","unstructured":"Fisher LM, Lawrence JM, Josty IC, Hopewell R, Margerrison EE, Cullen ME (1989) Ciprofloxacin and the fluoroquinolones: New concepts on the mechanism of action and resistance. Am J Med 87:2S\u20138S","journal-title":"Am J Med"},{"key":"6358_CR12","doi-asserted-by":"crossref","unstructured":"Nicholls P, Clark JR, Gu Liu C, Terwilliger A, Maresso AW (2023) Class-driven synergy and antagonism between a Pseudomonas phage and antibiotics. Infect Immun 91:e00065\u2013e00023","DOI":"10.1128\/iai.00065-23"},{"key":"6358_CR13","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1021\/cb3005116","volume":"8","author":"B Becker","year":"2013","unstructured":"Becker B, Cooper MA (2013) Aminoglycoside antibiotics in the 21st century. ACS Chem Biol 8:105\u2013115","journal-title":"ACS Chem Biol"},{"key":"6358_CR14","first-page":"726","volume-title":"The effect of streptomycin and other aminoglycoside antibiotics on protein synthesis","author":"G Jacoby","year":"1967","unstructured":"Jacoby G, Gorini L (1967) The effect of streptomycin and other aminoglycoside antibiotics on protein synthesis. Volume I Mechanism of Action. Springer, Antibiotics, pp 726\u2013747"},{"key":"6358_CR15","doi-asserted-by":"publisher","first-page":"e0078322","DOI":"10.1128\/mbio.00783-22","volume":"13","author":"L Kever","year":"2022","unstructured":"Kever L, Hardy A, Luthe T, Hunnefeld M, Gatgens C, Milke L, Wiechert J, Wittmann J, Moraru C, Marienhagen J, Frunzke J (2022) Aminoglycoside antibiotics inhibit phage infection by blocking an early step of the infection cycle. mBio 13:e0078322","journal-title":"mBio"},{"key":"6358_CR16","doi-asserted-by":"publisher","first-page":"e0042724","DOI":"10.1128\/spectrum.00427-24","volume":"12","author":"AJ Kunz Coyne","year":"2024","unstructured":"Kunz Coyne AJ, Eshaya M, Bleick C, Vader S, Biswas B, Wilson M, Deschenes MV, Alexander J, Lehman SM, Rybak MJ (2024) Exploring synergistic and antagonistic interactions in phage-antibiotic combinations against ESKAPE pathogens. Microbiol Spectr 12:e0042724","journal-title":"Microbiol Spectr"},{"key":"6358_CR17","doi-asserted-by":"crossref","unstructured":"Wosten MM, Boeve M, Koot MG, van Nuenen AC, van der Zeijst BA (1998) Identification of Campylobacter jejuni promoter sequences. J Bacteriol 180:594\u2013599","DOI":"10.1128\/JB.180.3.594-599.1998"},{"key":"6358_CR18","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/0378-1119(77)90000-2","volume":"2","author":"F Bolivar","year":"1977","unstructured":"Bolivar F, Rodriguez RL, Greene PJ, Betlach MC, Heyneker HL, Boyer HW, Crosa JH, Falkow S (1977) Construction and characterization of new cloning vehicles. II. A multipurpose cloning system. Gene 2:95\u2013113","journal-title":"Gene"},{"key":"6358_CR19","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1128\/jb.134.3.1141-1156.1978","volume":"134","author":"AC Chang","year":"1978","unstructured":"Chang AC, Cohen SN (1978) Construction and characterization of amplifiable multicopy DNA cloning vehicles derived from the P15A cryptic miniplasmid. J Bacteriol 134:1141\u20131156","journal-title":"J Bacteriol"},{"key":"6358_CR20","doi-asserted-by":"publisher","first-page":"6640","DOI":"10.1073\/pnas.120163297","volume":"97","author":"KA Datsenko","year":"2000","unstructured":"Datsenko KA, Wanner BL (2000) One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci U S A 97:6640\u20136645","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6358_CR21","doi-asserted-by":"publisher","first-page":"4121","DOI":"10.1128\/jb.177.14.4121-4130.1995","volume":"177","author":"LM Guzman","year":"1995","unstructured":"Guzman LM, Belin D, Carson MJ, Beckwith J (1995) Tight regulation, modulation, and high-level expression by vectors containing the arabinose PBAD promoter. J Bacteriol 177:4121\u20134130","journal-title":"J Bacteriol"},{"key":"6358_CR22","doi-asserted-by":"crossref","unstructured":"Bouras G, Nepal R, Houtak G, Psaltis AJ, Wormald PJ, Vreugde S (2023) Pharokka: a fast scalable bacteriophage annotation tool. Bioinformatics 39","DOI":"10.1093\/bioinformatics\/btac776"},{"key":"6358_CR23","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1124\/mol.110.068130","volume":"79","author":"MG Leitner","year":"2011","unstructured":"Leitner MG, Halaszovich CR, Oliver D (2011) Aminoglycosides inhibit KCNQ4 channels in cochlear outer hair cells via depletion of phosphatidylinositol (4,5)-bisphosphate. Mol Pharmacol 79:51\u201360","journal-title":"Mol Pharmacol"},{"key":"6358_CR24","doi-asserted-by":"crossref","unstructured":"Kim M, Ryu S (2011) Characterization of a T5-like coliphage, SPC35, and differential development of resistance to SPC35 in Salmonella enterica serovar Typhimurium and Escherichia coli. Appl Environ Microbiol 77:2042\u20132050","DOI":"10.1128\/AEM.02504-10"},{"key":"6358_CR25","doi-asserted-by":"crossref","unstructured":"Kim J, Park H, Ryu S, Jeon B (2021) Inhibition of antimicrobial-resistant Escherichia coli using a broad host range phage cocktail targeting various bacterial phylogenetic groups. Front Microbiol 12:699630","DOI":"10.3389\/fmicb.2021.699630"},{"key":"6358_CR26","doi-asserted-by":"crossref","unstructured":"Fuller-Schaefer CA, Kadner RJ (2005) Multiple extracellular loops contribute to substrate binding and transport by the Escherichia coli cobalamin transporter BtuB. J Bacteriol 187:1732\u20131739","DOI":"10.1128\/JB.187.5.1732-1739.2005"},{"key":"6358_CR27","doi-asserted-by":"publisher","first-page":"uqad044","DOI":"10.1093\/femsml\/uqad044","volume":"4","author":"M Skutel","year":"2023","unstructured":"Skutel M, Andriianov A, Zavialova M, Kirsanova M, Shodunke O, Zorin E, Golovshchinskii A, Severinov K, Isaev A (2023) T5-like phage BF23 evades host-mediated DNA restriction and methylation. Microlife 4:uqad044","journal-title":"Microlife"},{"key":"6358_CR28","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","volume":"399","author":"C Antimicrobial Resistance","year":"2022","unstructured":"Antimicrobial Resistance C (2022) Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet 399:629\u2013655","journal-title":"Lancet"},{"key":"6358_CR29","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.chom.2019.01.014","volume":"25","author":"KE Kortright","year":"2019","unstructured":"Kortright KE, Chan BK, Koff JL, Turner PE (2019) Phage therapy: A renewed approach to combat antibiotic-resistant bacteria. Cell Host Microbe 25:219\u2013232","journal-title":"Cell Host Microbe"},{"key":"6358_CR30","doi-asserted-by":"publisher","first-page":"4714","DOI":"10.1038\/s41467-023-40427-2","volume":"14","author":"J Abellon-Ruiz","year":"2023","unstructured":"Abellon-Ruiz J, Jana K, Silale A, Frey AM, Basle A, Trost M, Kleinekathofer U, van den Berg B (2023) BtuB TonB-dependent transporters and BtuG surface lipoproteins form stable complexes for vitamin B(12) uptake in gut Bacteroides. Nat Commun 14:4714","journal-title":"Nat Commun"},{"key":"6358_CR31","doi-asserted-by":"publisher","first-page":"3476","DOI":"10.1128\/JB.183.11.3476-3487.2001","volume":"183","author":"H Killmann","year":"2001","unstructured":"Killmann H, Braun M, Herrmann C, Braun V (2001) FhuA barrel-cork hybrids are active transporters and receptors. J Bacteriol 183:3476\u20133487","journal-title":"J Bacteriol"},{"key":"6358_CR32","doi-asserted-by":"crossref","unstructured":"Hancock RE, Farmer SW, Li ZS, Poole K (1991) Interaction of aminoglycosides with the outer membranes and purified lipopolysaccharide and OmpF porin of Escherichia coli. Antimicrob Agents Chemother 35:1309\u20131314","DOI":"10.1128\/AAC.35.7.1309"},{"key":"6358_CR33","doi-asserted-by":"crossref","unstructured":"Tanabe T, Miyamoto K, Tsujibo H, Yamamoto S, Funahashi T (2015) The small RNA Spot 42 regulates the expression of the type III secretion system 1 (T3SS1) chaperone protein VP1682 in Vibrio parahaemolyticus. FEMS Microbiol Lett 362","DOI":"10.1093\/femsle\/fnv173"},{"key":"6358_CR34","doi-asserted-by":"crossref","unstructured":"Gomara M, Ramon-Garcia S (2019) The FICI paradigm: Correcting flaws in antimicrobial in vitro synergy screens at their inception. Biochem Pharmacol 163:299\u2013307","DOI":"10.1016\/j.bcp.2019.03.001"},{"key":"6358_CR35","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.ijantimicag.2015.06.008","volume":"46","author":"JA Dijkstra","year":"2015","unstructured":"Dijkstra JA, van Altena R, Akkerman OW, de Lange WC, Proost JH, van der Werf TS, Kosterink JG, Alffenaar JW (2015) Limited sampling strategies for therapeutic drug monitoring of amikacin and kanamycin in patients with multidrug-resistant tuberculosis. Int J Antimicrob Agents 46:332\u2013337","journal-title":"Int J Antimicrob Agents"},{"key":"6358_CR36","unstructured":"Organization WH (2008) Guidelines for the programmatic management of drug resistant tuberculosis: Emergency update 2008. World Health Organization"},{"key":"6358_CR37","doi-asserted-by":"publisher","first-page":"e1011602","DOI":"10.1371\/journal.ppat.1011602","volume":"19","author":"J Bulssico","year":"2023","unstructured":"Bulssico J, Papukashvili I, Espinosa L, Gandon S, Ansaldi M (2023) Phage-antibiotic synergy: Cell filamentation is a key driver of successful phage predation. PLoS Pathog 19:e1011602","journal-title":"PLoS Pathog"},{"key":"6358_CR38","doi-asserted-by":"crossref","unstructured":"Gordillo Altamirano FL, Kostoulias X, Subedi D, Korneev D, Peleg AY, Barr JJ (2022) Phage-antibiotic combination is a superior treatment against Acinetobacter baumannii in a preclinical study. EBioMedicine 80:104045","DOI":"10.1016\/j.ebiom.2022.104045"},{"key":"6358_CR39","doi-asserted-by":"publisher","first-page":"e202300339","DOI":"10.1002\/minf.202300339","volume":"43","author":"J Revillo Imbernon","year":"2024","unstructured":"Revillo Imbernon J, Weibel JM, Ennifar E, Prevost G, Kellenberger E (2024) Structural analysis of neomycin B and kanamycin A binding aminoglycosides modifying enzymes (AME) and bacterial ribosomal RNA. Mol Inf 43:e202300339","journal-title":"Mol Inf"},{"key":"6358_CR40","doi-asserted-by":"crossref","unstructured":"Woegerbauer M, Zeinzinger J, Springer B, Hufnagl P, Indra A, Korschineck I, Hofrichter J, Kopacka I, Fuchs R, Steinwider J, Fuchs K, Nielsen KM, Allerberger F (2014) Prevalence of the aminoglycoside phosphotransferase genes aph(3')-IIIa and aph(3')-IIa in Escherichia coli, Enterococcus faecalis, Enterococcus faecium, Pseudomonas aeruginosa, Salmonella enterica subsp. enterica and Staphylococcus aureus isolates in Austria. J Med Microbiol 63:210\u2013217","DOI":"10.1099\/jmm.0.065789-0"},{"key":"6358_CR41","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.drup.2010.08.003","volume":"13","author":"MS Ramirez","year":"2010","unstructured":"Ramirez MS, Tolmasky ME (2010) Aminoglycoside modifying enzymes. Drug Resist Updat 13:151\u2013171","journal-title":"Drug Resist Updat"}],"container-title":["Archives of Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00705-025-06358-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00705-025-06358-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00705-025-06358-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T00:50:03Z","timestamp":1757206203000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00705-025-06358-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,3]]},"references-count":41,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["6358"],"URL":"https:\/\/doi.org\/10.1007\/s00705-025-06358-7","relation":{},"ISSN":["0304-8608","1432-8798"],"issn-type":[{"value":"0304-8608","type":"print"},{"value":"1432-8798","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,3]]},"assertion":[{"value":"25 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"172"}}